Themis Medicare’s anti-viral COVID drug gets DCGI nod
2 months ago•Economic Times
Themis gets Drug Controller’s nod to launch Inosine Pranobex a novel medicine to treat Covid19, A Viral Infection
2 months ago•Economic Times
Stocks that will see action today (March 4)
2 months ago•The Hindu Businessline
Themis Medicare Consolidated December 2021 Net Sales at Rs 94.92 crore, up 44.88% Y-o-Y
2 months ago•Moneycontrol
Themis Medicare receives approval for COVID drug from DCGI
2 months ago•Business Standard
Themis Medicare incorporates new subsidiary company ‘Carpo Investments’
4 months ago•India Infoline
Acuite rates Themis Medicare’s bank loan facilities at ‘BBB-/Stable’
5 months ago•India Infoline
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Current price is less than the intrinsic value